Speaker
Allan Langlois
Strasbourg University, France
Biography :
Dr Allan LANGLOIS is associate laboratory director at the European Centre for the Study of Diabetes. Throughout his career, he has been interested in understanding insulin secretion mechanisms, in particular insulin granules trafficking, in order to develop protective strategies to prevent β-cell destruction and dysfunction. Indeed, the preservation of a physiological insulin secretion by protecting pancreatic β-cells is the major challenge to prevent and treat diabetes. In this context, Dr Allan LANGLOIS is also invested in pancreatic islet transplantation therapeutic strategy for T1DM, to develop solutions to maintain a long-term functional mass of pancreatic β- cells.
